XXEC Inc. boosted its position in shares of Proto Labs, Inc. (NYSE:PRLB - Free Report) by 433.6% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 311,607 shares of the industrial products company's stock after acquiring an additional 253,214 shares during the period. Proto Labs accounts for 0.0% of XXEC Inc.'s holdings, making the stock its 17th biggest position. XXEC Inc. owned 1.30% of Proto Labs worth $27,557,000 at the end of the most recent quarter.
Several other institutional investors also recently bought and sold shares of the company. Group One Trading LLC acquired a new position in shares of Proto Labs during the fourth quarter worth $25,000. NewEdge Advisors LLC boosted its position in shares of Proto Labs by 7,380.0% in the 1st quarter. NewEdge Advisors LLC now owns 748 shares of the industrial products company's stock worth $26,000 after purchasing an additional 738 shares in the last quarter. NBC Securities Inc. purchased a new position in Proto Labs during the 4th quarter worth $46,000. USA Financial Formulas purchased a new stake in Proto Labs in the first quarter valued at about $52,000. Finally, Modus Advisors LLC purchased a new stake in Proto Labs in the fourth quarter valued at about $57,000. 84.54% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of equities research analysts have recently weighed in on PRLB shares. Zacks Research upgraded Proto Labs from a "hold" rating to a "strong-buy" rating in a research note on Thursday, August 6th. Weiss Ratings lowered shares of Proto Labs from a "buy (b)" rating to a "buy (b-)" rating in a research report on Tuesday, August 18th. Needham & Company LLC raised shares of Proto Labs from a "hold" rating to a "buy" rating and set a $87.00 target price on the stock in a research report on Monday, August 3rd. Benchmark upped their price target on shares of Proto Labs from $70.00 to $91.00 and gave the company a "buy" rating in a research note on Thursday, July 2nd. Finally, Wall Street Zen downgraded Proto Labs from a "strong-buy" rating to a "buy" rating in a research report on Saturday, July 18th. One equities research analyst has rated the stock with a Strong Buy rating and three have given a Buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Buy" and an average target price of $89.00.
View Our Latest Analysis on Proto Labs
Proto Labs Stock Up 1.7%
Shares of NYSE PRLB opened at $80.20 on Friday. Proto Labs, Inc. has a 52 week low of $45.10 and a 52 week high of $93.00. The business's 50 day moving average price is $80.46 and its 200 day moving average price is $70.91. The firm has a market cap of $1.92 billion, a P/E ratio of 64.16 and a beta of 1.40.
Proto Labs (NYSE:PRLB - Get Free Report) last posted its quarterly earnings results on Friday, July 31st. The industrial products company reported $0.60 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.53 by $0.07. Proto Labs had a net margin of 5.44% and a return on equity of 4.80%. The company had revenue of $149.34 million during the quarter, compared to analyst estimates of $144.53 million. During the same period last year, the firm posted $0.41 EPS. Proto Labs's revenue for the quarter was up 10.5% compared to the same quarter last year. Proto Labs has set its Q3 2026 guidance at 0.560-0.640 EPS. As a group, research analysts expect that Proto Labs, Inc. will post 1.46 earnings per share for the current year.
Insider Transactions at Proto Labs
In other Proto Labs news, Director Sven Wehrwein sold 2,000 shares of the company's stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $77.28, for a total value of $154,560.00. Following the sale, the director directly owned 32,505 shares of the company's stock, valued at approximately $2,511,986.40. This represents a 5.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.30% of the stock is owned by corporate insiders.
Proto Labs Company Profile
(
Free Report)
Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.
Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Proto Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Proto Labs wasn't on the list.
While Proto Labs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.